AU2003293723A1 - 3-pyrrolyl urea derivatives and their use as antiviral agents - Google Patents
3-pyrrolyl urea derivatives and their use as antiviral agentsInfo
- Publication number
- AU2003293723A1 AU2003293723A1 AU2003293723A AU2003293723A AU2003293723A1 AU 2003293723 A1 AU2003293723 A1 AU 2003293723A1 AU 2003293723 A AU2003293723 A AU 2003293723A AU 2003293723 A AU2003293723 A AU 2003293723A AU 2003293723 A1 AU2003293723 A1 AU 2003293723A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrrolyl
- antiviral agents
- urea derivatives
- urea
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10257358A DE10257358A1 (en) | 2002-12-09 | 2002-12-09 | Substituted pyrroles |
DE10257358.1 | 2002-12-09 | ||
PCT/EP2003/013278 WO2004052852A1 (en) | 2002-12-09 | 2003-11-26 | 3-pyrrolyl urea derivatives and their use as antiviral agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003293723A1 true AU2003293723A1 (en) | 2004-06-30 |
Family
ID=32477461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003293723A Abandoned AU2003293723A1 (en) | 2002-12-09 | 2003-11-26 | 3-pyrrolyl urea derivatives and their use as antiviral agents |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1572642A1 (en) |
AU (1) | AU2003293723A1 (en) |
CA (1) | CA2508788A1 (en) |
DE (1) | DE10257358A1 (en) |
WO (1) | WO2004052852A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004015007A1 (en) | 2004-03-26 | 2005-10-13 | Bayer Healthcare Ag | Substituted imidazoles |
DE102005008183A1 (en) | 2005-02-23 | 2006-08-31 | Bayer Healthcare Ag | New heterocyclylamide-substituted imidazole compounds useful to treat or prevent viral infections |
DE102005033103A1 (en) * | 2005-07-15 | 2007-01-25 | Bayer Healthcare Ag | Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
TWI361808B (en) * | 2008-01-08 | 2012-04-11 | Nat Health Research Institutes | Imidazolidinone and imidazolidinethione derivatives |
DE102011113749A1 (en) * | 2011-09-14 | 2013-03-14 | Aicuris Gmbh & Co. Kg | Sulfonic acid salts heterocyclylamide substituted imidazoles |
LT3024819T (en) * | 2013-07-25 | 2018-06-11 | Janssen Sciences Ireland Uc | Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
WO2016183266A1 (en) * | 2015-05-13 | 2016-11-17 | Enanta Pharmaceuticals, Inc. | Ehpatitis b antiviral agents |
ES2938341T3 (en) | 2016-03-07 | 2023-04-10 | Enanta Pharm Inc | Antiviral agents against hepatitis B |
CN108250121A (en) * | 2016-12-28 | 2018-07-06 | 上海长森药业有限公司 | Sulfonamide-arylamides and its medicinal usage for treating hepatitis B |
WO2019046271A1 (en) | 2017-08-28 | 2019-03-07 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
WO2019143902A2 (en) | 2018-01-22 | 2019-07-25 | Enanta Pharmaceuticals, Inc. | Substituted heterocycles as antiviral agents |
WO2019191166A1 (en) | 2018-03-29 | 2019-10-03 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
MX2021003253A (en) | 2018-09-21 | 2021-08-11 | Enanta Pharm Inc | Functionalized heterocycles as antiviral agents. |
AU2019385477A1 (en) | 2018-11-21 | 2021-06-10 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
WO2020247444A1 (en) | 2019-06-03 | 2020-12-10 | Enanta Pharmaceuticals, Inc, | Hepatitis b antiviral agents |
WO2020247561A1 (en) | 2019-06-04 | 2020-12-10 | Enanta Pharmaceuticals, Inc, | Hepatitis b antiviral agents |
WO2020247575A1 (en) | 2019-06-04 | 2020-12-10 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
WO2021007488A1 (en) | 2019-07-11 | 2021-01-14 | Enanta Pharmaceuticals, Inc. | Substituted heterocycles as antiviral agents |
US11236108B2 (en) | 2019-09-17 | 2022-02-01 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
US11802125B2 (en) | 2020-03-16 | 2023-10-31 | Enanta Pharmaceuticals, Inc. | Functionalized heterocyclic compounds as antiviral agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69826695T2 (en) * | 1997-05-23 | 2006-02-02 | Bayer Pharmaceuticals Corp., West Haven | ARYLENE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY OR IMMUNOMODULATORY DISEASES |
WO1999023091A1 (en) * | 1997-11-03 | 1999-05-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds as anti-inflammatory agents |
-
2002
- 2002-12-09 DE DE10257358A patent/DE10257358A1/en not_active Withdrawn
-
2003
- 2003-11-26 EP EP03789084A patent/EP1572642A1/en not_active Withdrawn
- 2003-11-26 CA CA002508788A patent/CA2508788A1/en not_active Abandoned
- 2003-11-26 WO PCT/EP2003/013278 patent/WO2004052852A1/en not_active Application Discontinuation
- 2003-11-26 AU AU2003293723A patent/AU2003293723A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004052852A1 (en) | 2004-06-24 |
EP1572642A1 (en) | 2005-09-14 |
DE10257358A1 (en) | 2004-07-08 |
CA2508788A1 (en) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1800002I1 (en) | O-cyclopropyl-carboxanilides and their use as fungicides | |
AU2003293723A1 (en) | 3-pyrrolyl urea derivatives and their use as antiviral agents | |
EP2617709B8 (en) | Guanidine derivatives as antiviral agents | |
AU2003249909A1 (en) | Phenoxypropenylphenyl derivatives and their use as herbicides | |
AP2004003110A0 (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
AU2003266321A1 (en) | Tetrahydropyrimidine-2-one derivatives and their uses | |
IL166552A0 (en) | Pyrimidine derivatives and their use as cb2 modulators | |
PL377160A1 (en) | Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides | |
AU2914200A (en) | Thiazolyl urea derivatives and their utilization as antiviral agents | |
AU2003295402A1 (en) | Acyl guanidine compounds and use thereof | |
AU2003202091A1 (en) | Guanidine derivatives | |
IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
AU2003216221A1 (en) | Attachment and articles using same | |
AU2003231947A1 (en) | Defensins: use as antiviral agents | |
AU2003292381A1 (en) | Naphthyridine derivatives and their use as fungicides | |
AU2003303678A1 (en) | Urea derivatives and their use as anti-inflammatory agents | |
AU2003274351A1 (en) | Substituted pyridyloxyalkylamides and their use as fungicides | |
AU2003290816A1 (en) | Modified nucleosides as antiviral agents | |
AU2003242405A1 (en) | Compounds and preparaitons having antiviral effect | |
AU2003252684A1 (en) | N-acetylglucosamine derivatives and use thereof | |
AU2003273803A1 (en) | Use of triptans as antiviral agents | |
AU2003269950A1 (en) | Heteroaryl-ethanolamine derivatives as antiviral agents | |
AU2003205963A1 (en) | Azaphenylalanine derivatives and their use as antithrombotic agents | |
AU2003304151A1 (en) | Heteroaryl-ethanolamine derivatives as antiviral agents | |
ZA200410062B (en) | Novel adenosine analogues and their use as pharmaceutical agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |